Document is current
Any future updates will be listed below
-
Authors
Altstidl, J. Michael https://orcid.org/0000-0002-7395-8151
Achenbach, Stephan https://orcid.org/0000-0002-7596-095X
Günes-Altan, Merve https://orcid.org/0009-0005-3770-6562
Moshage, Maximilian
Weidinger, Florian
Huber, Katharina
Tröbs, Monique https://orcid.org/0000-0002-5661-1017
Marwan, Mohamed https://orcid.org/0000-0001-8759-4101
Gaede, Luise https://orcid.org/0000-0002-9678-908X
-
Funding
Funding for this research was provided by:
Bayerische Staatsministerium für Wirtschaft, Landesentwicklung und Energie (LSM-2007-0002)
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 25 October 2025
Accepted: 23 December 2025
First Online: 26 January 2026
Declarations
:
: J. Michael Altstidl received speaker honorarium from Edwards Lifesciences. Luise Gaede received speaker honorarium from Abiomed, Abbott Laboratories, AstraZeneca, Boston Scientific, Edwards Lifesciences, Siemens Healthineers, SMT, and Shockwave Medical. Merve Günes-Altan received travel support from Eli Lilly and Company. Mohamed Marwan received speaker honorarium from Edwards Lifesciences and Siemens Healthineers. Maximilian Moshage received travel support from Eli Lilly and Company. Monique Tröbs received speaker honorarium from Abbott Laboratories, Pfizer, and Bristol Myers Squibb, travel support from Abbott Laboratories and Edwards Lifesciences, and participates in the Pfizer Advisory Board. All other authors have no conflicts of interest to declare that are relevant to the content of this article.
